7 months ago
Cross-Border Medical Innovation: Singaporean Patient Confronts Multiple Myeloma in China – A Decisive Journey with CAR-T Therapy Multiple Myeloma Singaporean patient, Teresa has been batt...
7 months ago
Carvykti Price and Brief Introduction Ciltacabtagene Autoleucel, a CAR-T product from China, received FDA approval in March 2022 and EU approval on May 26th of the same year, marking an unprecedent...
7 months ago
跨境医疗创新：新加坡患者在中国迎战骨髓瘤——一次CAR-T治疗的决定性旅程 多发性骨髓瘤，患者故事 新加坡患者Teresa女士，经历了近三年与多发性骨髓瘤的斗争，她目前在多线药物治疗、放化疗后仍面临病...
7 months ago
Carvykti FDA Approval for the Treatment of Relapsed or Refractory Multiple Myeloma FDA Approves The Listing Of Carvykti On February 28, 2022, Legend Biotech Corporation (LEGN) announced that the U....
7 months ago
🍒🍎Journey of an Indian Cancer Patient to China: Bringing Gratitude Back to India!🍒🍎 Cancer Patient 🍅“Before coming to China for treatment, I had many concerns because my condition was very pe...
7 months ago
Preparations Before Myeloma CAR-T Therapy: Dual Evaluation of Physical Condition and Disease Status to Ensure Smooth Treatment Dear readers, if you or someone around you is about to undergo CAR-T c...
7 months ago
Multiple Myeloma CAR-T Treatment Strategy:From Preparation TO Management,One Can Understand! Would you like to understand the entire process of CAR-T cell infusion? This comprehensive guide covers ...
7 months ago
🌈 $160,000 per dose! 🌈 ⭐The first approved CAR-T therapy in China, Zevor-cel by CARsgen, announces its initial price for the treatment of multiple myeloma. multiple myeloma Zevor-cel ...
7 months ago
Carvykti(Ciltacabtagene Autoleucel) Recommended for Approval by CHMP for Front-line Treatment of Multiple Myeloma On February 23, 2024, Legend Biotech announced that the Committee for Medicinal Pro...
7 months ago
Carvykti(Ciltacabtagene Autoleucel):A Breakthrough in CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Legend Biotech and Janssen Biotech Inc. entered into a collaboration agreement in D...
7 months ago
🎉 Chinese Medicine Team Achieves Global Milestone: First Successful Treatment of Pancreatic Cancer Patient with Innovative Dual-Targeted CAR-T Cell Therapy (KD-496)! Dual-Targeted CAR-T ...
7 months ago
CAR-T And Multiple Myeloma:The Road Ahead for CAR-T Cell Therapy in Multiple Myeloma,Arduous yet Promising In the near future, CAR-T cell therapy products for multiple myeloma will gradually be lau...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
